Literature DB >> 7880799

Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?

A D Dick1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7880799      PMCID： PMC505026          DOI： 10.1136/bjo.79.1.81

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  76 in total

Review 1.  Revisiting and revising suppressor T cells.

Authors:  B R Bloom; P Salgame; B Diamond
Journal:  Immunol Today       Date:  1992-04

2.  Distribution of IL-2R and CD45Ro expression on CD4+ and CD8+ T-lymphocytes in the peripheral blood of patients with posterior uveitis.

Authors:  E J Feron; V L Calder; S L Lightman
Journal:  Curr Eye Res       Date:  1992       Impact factor: 2.424

3.  Humanised monoclonal antibody therapy for rheumatoid arthritis.

Authors:  J D Isaacs; R A Watts; B L Hazleman; G Hale; M T Keogan; S P Cobbold; H Waldmann
Journal:  Lancet       Date:  1992-09-26       Impact factor: 79.321

4.  Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

Authors:  R O Williams; M Feldmann; R N Maini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

5.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

Authors:  D J Lenschow; Y Zeng; J R Thistlethwaite; A Montag; W Brady; M G Gibson; P S Linsley; J A Bluestone
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

6.  Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducin.

Authors:  H S Dua; R H Lee; R N Lolley; J A Barrett; M Abrams; J V Forrester; L A Donoso
Journal:  Curr Eye Res       Date:  1992       Impact factor: 2.424

7.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1.

Authors:  M Isobe; H Yagita; K Okumura; A Ihara
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

8.  Transforming growth factor-beta 1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures.

Authors:  L D Johns; G Babcock; D Green; M Freedman; S Sriram; R M Ransohoff
Journal:  Brain Res       Date:  1992-07-10       Impact factor: 3.252

9.  Low-dose cyclosporin therapy of ocular inflammation: preliminary report of a long-term follow-up study.

Authors:  H M Towler; S L Lightman; J V Forrester
Journal:  J Autoimmun       Date:  1992-04       Impact factor: 7.094

Review 10.  Cytokines and uveitis, a review.

Authors:  A F De Vos; R Hoekzema; A Kijlstra
Journal:  Curr Eye Res       Date:  1992-06       Impact factor: 2.424
View more
  7 in total

1.  Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.

Authors:  B Laliotou; J Liversidge; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

Review 2.  Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.

Authors:  A D Dick; M Azim; J V Forrester
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

3.  Molecular analysis of resolving immune responses in uveitis.

Authors:  P I Murray; C D Clay; C Mappin; M Salmon
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

4.  Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.

Authors:  D A Copland; K Hussain; S Baalasubramanian; T R Hughes; B P Morgan; H Xu; A D Dick; L B Nicholson
Journal:  Clin Exp Immunol       Date:  2009-12-04       Impact factor: 4.330

5.  Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier.

Authors:  David A Copland; Jian Liu; Lauren P Schewitz-Bowers; Volker Brinkmann; Karen Anderson; Lindsay B Nicholson; Andrew D Dick
Journal:  Am J Pathol       Date:  2011-11-24       Impact factor: 4.307

6.  Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.

Authors:  Fouad R Zakka; Peter Y Chang; Gian P Giuliari; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2009-10-19

Review 7.  Cytokines and Biologics in non-infectious autoimmune uveitis: bench to bedside.

Authors:  Rupesh Agrawal; Jayant Iyer; John Connolly; Daiju Iwata; Stephen Teoh
Journal:  Indian J Ophthalmol       Date:  2014-01       Impact factor: 1.848
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.